We are live on ! Find out more
BCM

Bratton Capital Management Portfolio holdings

AUM $40.7M
1-Year Est. Return 43.1%
This Fund
S&P 500
This Quarter Est. Return
-24.83%
1 Year Est. Return
+43.1%
3 Year Est. Return
+264.04%
5 Year Est. Return
-20.19%
10 Year Est. Return
AUM
$51.2M
AUM Growth
-$16.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQST icon
1
Aquestive Therapeutics
AQST
$452M
$36.6M 71.47%
11,503,294
DNLI icon
2
Denali Therapeutics
DNLI
$3.79B
$14.6M 28.53%
953,035

Similar funds

Bratton Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Bratton Capital Management held 2 positions worth $51.2M, down 25% from $68.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Bratton Capital Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Bratton Capital Management's ten largest holdings make up 100% of its $51.2M portfolio in Q3 2019.
  • Bratton Capital Management opened 0 new positions and closed 0 in Q3 2019.
  • Bratton Capital Management's portfolio value fell 25% quarter-over-quarter to $51.2M.

Based on Bratton Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.